Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Islet transplantation into brown adipose tissue can delay immune rejection
Jessica D. Kepple, Jessie M. Barra, Martin E. Young, Chad S. Hunter, Hubert M. Tse
Jessica D. Kepple, Jessie M. Barra, Martin E. Young, Chad S. Hunter, Hubert M. Tse
View: Text | PDF
Research Article Endocrinology Transplantation

Islet transplantation into brown adipose tissue can delay immune rejection

  • Text
  • PDF
Abstract

Type 1 diabetes is an autoimmune disease characterized by insulin-producing β cell destruction. Although islet transplantation restores euglycemia and improves patient outcomes, an ideal transplant site remains elusive. Brown adipose tissue (BAT) has a highly vascularized and antiinflammatory microenvironment. Because these tissue features can promote islet graft survival, we hypothesized that islets transplanted into BAT will maintain islet graft and BAT function while delaying immune-mediated rejection. We transplanted syngeneic and allogeneic islets into BAT or under the kidney capsule of streptozotocin-induced diabetic NOD.Rag and NOD mice to investigate islet graft function, BAT function, metabolism, and immune-mediated rejection. Islet grafts within BAT restored euglycemia similarly to kidney capsule controls. Islets transplanted in BAT maintained expression of islet hormones and transcription factors and were vascularized. Compared with those in kidney capsule and euglycemic mock-surgery controls, no differences in glucose or insulin tolerance, thermogenic regulation, or energy expenditure were observed with islet grafts in BAT. Immune profiling of BAT revealed enriched antiinflammatory macrophages and T cells. Compared with the kidney capsule control, there were significant delays in autoimmune and allograft rejection of islets transplanted in BAT, possibly due to increased antiinflammatory immune populations. Our data support BAT as an alternative islet transplant site that may improve graft survival.

Authors

Jessica D. Kepple, Jessie M. Barra, Martin E. Young, Chad S. Hunter, Hubert M. Tse

×

Figure 3

Islet transplantation into BAT does not affect energy expenditure and thermogenesis.

Options: View larger image (or click on image) Download as PowerPoint
Islet transplantation into BAT does not affect energy expenditure and th...
(A) Assessment of BW during the transplant experiment. (B) Body composition, including lean and fat mass, was assessed for all groups via quantitative magnetic resonance; BAT (n = 5), kidney control (n = 3), euglycemic mock control (Eugly. mock; n = 8), diabetic control (n = 7). (C) BAT mass from all groups: BAT (n = 7), kidney (n = 10), Eugly. mock (n = 10), and diabetic (n = 8). (D) qRT-PCR analysis of gene expression from BAT in each group assessing BAT markers and TFs (n = 4–6). (E) H&E staining of BAT from all groups (n = 3) at ×40 magnification. (F) Indirect calorimetry analysis of the kidney (n = 3), BAT (n = 5), and Eugly. mock (n = 4) control groups. Energy expenditure measured at 26°C, 24°C, and 22°C in chow-fed mice. (G) Cold challenge conducted for 3 hours at 4°C at 8–9 weeks (n = 9–10). Body composition and energy expenditure analyzed by 1-way or 2-way ANOVA with Tukey post hoc test, compared with Eugly. mock. For BW analysis, the letters represent significant differences between the Eugly. mock and (a) kidney, (b) BAT, and (c) diabetic control. Data represent at least 3 independent experiments. Error bars are ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts